back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2015-10-02 Tx date 2015-09-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$445,950
+2,500 vol $178.38 each |
45,350 | |
| Filed 2015-10-02 Tx date 2015-09-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-445,950
-2,500 vol $178.38 each |
24,175 | |
| Filed 2015-08-11 Tx date 2015-08-06 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$6,005,070
+24,175 vol $248.40 each |
42,850 | |
| Filed 2015-06-24 Tx date 2015-06-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,166,250
+5,000 vol $233.25 each |
18,675 | |
| Filed 2015-06-24 Tx date 2015-06-23 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-1,166,250
-5,000 vol $233.25 each |
26,675 | |
| Filed 2015-06-03 Tx date 2015-06-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,545,306
-14,900 vol $237.94 each |
||
| Filed 2015-06-03 Tx date 2015-06-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,475,012
-23,000 vol $238.04 each |
13,675 | |
| Filed 2015-06-03 Tx date 2015-06-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,000
-100 vol $240.00 each |
91,525 | |
| Filed 2015-06-03 Tx date 2015-06-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,545,306
-14,900 vol $237.94 each |
76,625 | |
| Filed 2015-06-03 Tx date 2015-06-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-760,049
-14,900 vol $51.01 each |
36,675 | |
| Filed 2015-06-03 Tx date 2015-06-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,101
+100 vol $51.01 each |
36,775 | |
| Filed 2015-06-03 Tx date 2015-06-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,000
-100 vol $240.00 each |
||
| Filed 2015-06-03 Tx date 2015-06-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,101
-100 vol $51.01 each |
36,675 | |
| Filed 2015-06-03 Tx date 2015-06-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$760,049
+14,900 vol $51.01 each |
51,575 | |
| Filed 2015-04-28 Tx date 2015-04-24 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$526,050
+2,500 vol $210.42 each |
36,675 | |
| Filed 2015-04-28 Tx date 2015-04-24 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
$-526,050
-2,500 vol $210.42 each |
31,675 | |
| Filed 2015-04-28 Tx date 2015-04-24 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Mirovsky, Pavel
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$-526,050
-2,500 vol $210.42 each |